Contineum Therapeutics, Inc.

CTNM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001855175

SEC filings (opens in a new tab)

In the last 90 days, Contineum Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 102 institutions reported holding it in 13F filings for Q2 2026, worth $500.6M in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.

Q2 2026 vs. Q1 2026

How the institutions holding Contineum Therapeutics, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026 All holders in Q1 2026

13F holders of CTNM: Q1 2026 compared with Q2 2026
Measure	Q1 2026	Of which not filed for Q2 2026	Q2 2026	Change
Holders	90	2	102	+14
Shares	30.6M	2.74M	30.5M	+2.73M (+9.8%)
Value	$398.9M	$35.6M	$500.6M	+$137.2M (+37.8%)

2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (29)

Institutions that held Contineum Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CTNM in Q2 2026
Institution	Shares	Value	% of portfolio
Jupiter Topco LLC	2,734,836	$44.8M	0.02%
Adage Capital Partners GP, L.L.C.	328,000	$5.38M	0.01%
Squadron Capital Management LLC	260,000	$4.26M	1.46%
Vanguard Portfolio Management LLC	180,302	$2.96M	0.00%
Diadema Partners LP	119,733	$1.96M	0.69%
Schonfeld Strategic Advisors LLC	69,441	$1.14M	0.01%
Bank of New York Mellon Corp	65,604	$1.08M	0.00%
Acuta Capital Partners, LLC	63,095	$1.03M	0.72%
Ameriprise Financial Inc	60,253	$987.5K	0.00%
Nuveen, LLC	35,707	$585.2K	0.00%
Alps Advisors Inc	33,210	$544.3K	0.00%
Persistent Asset Partners Ltd	33,037	$541.5K	0.17%
Rhumbline Advisers	31,098	$509.7K	0.00%
Deutsche Bank AG	26,216	$429.7K	0.00%
Wells Fargo & Company	22,510	$368.9K	0.00%
Allspring Global Investments Holdings, LLC	19,653	$322.1K	0.00%
MetLife Investment Management	16,447	$269.6K	0.00%
Invesco Ltd.	15,771	$258.5K	0.00%
Mirae Asset Global ETFs Holdings Ltd.	12,324	$202.0K	0.00%
New York State Common Retirement Fund	9,400	$154.1K	0.00%
Natixis	9,072	$144.0K	0.00%
Police & Firemen's Retirement System of New Jersey	7,927	$129.9K	0.00%
Legal & General Group Plc	2,614	$42.8K	0.00%
Ameritas Investment Partners, Inc.	2,439	$40.0K	0.00%
Russell Investments Group, Ltd.	2,140	$35.1K	0.00%
State of Wyoming	1,405	$23.0K	0.00%
Sterling Capital Management LLC	542	$8.88K	0.00%
California State Teachers Retirement System	370	$6.06K	0.00%
Optiver Holding B.V.	24	$393	0.00%

Sold out (15)

Institutions that held Contineum Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of CTNM in Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Baker Bros. Advisors LP	1,420,838	$18.6M
Ra Capital Management, L.P.	1,296,012	$16.9M
Jones Hill Capital LP	513,053	$6.70M
Jane Street Group, LLC	107,380	$1.40M
683 Capital Management, LLC	55,000	$718.3K
Acadian Asset Management LLC	54,068	$703.0K
Hudson Bay Capital Management LP	42,818	$559.2K
Brevan Howard Capital Management LP	42,178	$550.8K
Jain Global LLC	22,984	$300.2K
HRT Financial LP	22,170	$289.0K
Omers Administration Corp	14,200	$185.5K
Cannon Global Investment Management, LLC	13,000	$169.8K
Quadrature Capital Ltd	12,799	$167.2K
ExodusPoint Capital Management, LP	12,382	$161.7K
Diametric Capital, LP	10,729	$140.1K

Not filed for Q2 2026 yet (2)

Institutions that held Contineum Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CTNM in Q1 2026 that haven't filed for Q2 2026
Institution	Shares, Q1 2026	Value, Q1 2026
Janus Henderson Group PLC	2,734,836	$35.6M
CWM, LLC	1,145	$15.0K